| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/17/2009 | US7490603 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 02/17/2009 | CA2356087C Methods and compositions for treatment of cell proliferative disorders |
| 02/17/2009 | CA2355283C Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/17/2009 | CA2347856C Dry powder for inhalation |
| 02/17/2009 | CA2340934C Novel collectin |
| 02/17/2009 | CA2334267C Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 02/17/2009 | CA2325983C Drug delivery of proteins from polymeric blends |
| 02/17/2009 | CA2318030C Acpl dna and polypeptides |
| 02/17/2009 | CA2316411C Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 02/17/2009 | CA2301874C Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 02/17/2009 | CA2231404C Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/17/2009 | CA2180957C Cloning and recombinant production of crf receptor(s) |
| 02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/17/2009 | CA2121498C Recombitope peptides |
| 02/16/2009 | CA2640986A1 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues |
| 02/12/2009 | WO2009021155A1 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 02/12/2009 | WO2009021137A2 Kinase inhibitors and uses thereof |
| 02/12/2009 | WO2009021121A2 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto |
| 02/12/2009 | WO2009021022A2 Modulating the activity of nuclear receptors in order to treat hypoxia-related disorders |
| 02/12/2009 | WO2009020994A2 Ultrasound and microbubbles in ocular diagnostics and therapies |
| 02/12/2009 | WO2009020934A1 Composition for long-acting peptide analogs |
| 02/12/2009 | WO2009020844A1 Use of interleukin-22 in the treatment of fatty liver disease |
| 02/12/2009 | WO2009020802A2 Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity |
| 02/12/2009 | WO2009020744A1 Protein formulations comprising gdf-5 in aqueous acidic solution |
| 02/12/2009 | WO2009020643A2 Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| 02/12/2009 | WO2009020565A1 Use of phosphatases to treat neuroblastomas and medulloblastomas |
| 02/12/2009 | WO2009020559A2 Agents that inhibit p-tefb interactions and methods of use thereof |
| 02/12/2009 | WO2009020477A1 Modified miniature proteins |
| 02/12/2009 | WO2009020448A1 Proteasome inhibitors |
| 02/12/2009 | WO2009020434A1 A process for making micro-sized protein particles |
| 02/12/2009 | WO2009020419A1 New treatment for chemical substance addiction |
| 02/12/2009 | WO2009020405A1 Treating or preventing rotavirus infection |
| 02/12/2009 | WO2009020189A1 Anti-hypertensive agent |
| 02/12/2009 | WO2009019815A1 Novel γ-secretase inhibitor |
| 02/12/2009 | WO2009019614A2 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 02/12/2009 | WO2009019528A1 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 02/12/2009 | WO2009019465A1 Insulin-like growth factor fusion proteins |
| 02/12/2009 | WO2009019456A1 Interferon fusion proteins |
| 02/12/2009 | WO2009019433A2 Fertilisation protein |
| 02/12/2009 | WO2009019427A1 Leptin fusion proteins |
| 02/12/2009 | WO2009019314A1 Transferrin variants and conjugates |
| 02/12/2009 | WO2009019254A1 Igfbp-2 c-terminal fragments and uses thereof |
| 02/12/2009 | WO2009019117A1 Igf-1r binding polypeptides and their use |
| 02/12/2009 | WO2009018908A1 Synthetic pulmonary surfactant peptides |
| 02/12/2009 | WO2009018667A1 Plant bioreactor for the production of interleukin-24 cytokine |
| 02/12/2009 | WO2009018643A2 Use of pharmaceutical compound containing crotoxin for the treatment of muscle dystonias |
| 02/12/2009 | WO2009018625A1 Treatment of prion protein related diseases |
| 02/12/2009 | WO2009018623A1 Molecular markers and methods related thereto |
| 02/12/2009 | WO2009018622A1 Lactation-associated polypeptides |
| 02/12/2009 | WO2009009739A3 Methods and compositions for facilitating cell death of cancer stem cells and for treating cancer |
| 02/12/2009 | WO2009002811A3 Therapeutic platelet compositions and methods |
| 02/12/2009 | WO2009001260A3 Cosmetic use of apolipoprotein d type proteins |
| 02/12/2009 | WO2008154638A3 Antagonists of the receptor for advanced glycation end-products (rage) |
| 02/12/2009 | WO2008154083A3 Compounds, compositions and methods for the treatment of synucleinopathies |
| 02/12/2009 | WO2008150981A3 Novel short peptides that inhibit the opening of mammalian tight junctions |
| 02/12/2009 | WO2008145603A3 Pharmaceutical compositions comprising telomerase, and uses thereof |
| 02/12/2009 | WO2008145400A3 Mutated structural protein of a parvovirus |
| 02/12/2009 | WO2008142162A3 Pharmaceutical agent for the treatment of fertility and gestation disorders, immunological diseases, and transplantation for use in veterinary medicine, particularly in horses, and methods for the production and treatment monitoring thereof |
| 02/12/2009 | WO2008126932A3 Epigenetical regulation of brain plasticity |
| 02/12/2009 | WO2008113770A3 Anti-androgen peptides and uses thereof in cancer therapy |
| 02/12/2009 | WO2008105835A4 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 02/12/2009 | WO2008063147A3 Anthrax polypeptide binding |
| 02/12/2009 | WO2008028963A3 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 02/12/2009 | WO2008012089A8 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 02/12/2009 | WO2007105223A3 Methods of diagnosing pon1-hdl associated lipid disorders |
| 02/12/2009 | WO2007069247A3 Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same |
| 02/12/2009 | WO2006138729A3 Receptor antagonists for treatment of metastatic bone cancer |
| 02/12/2009 | WO2006055077A3 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom |
| 02/12/2009 | WO2006031980A3 Treatment for cancer-related fatigue |
| 02/12/2009 | WO2005086798A3 Improved interleukin-2 muteins |
| 02/12/2009 | US20090043399 Use of fucans for the purpose of bone grafting, engineering and regeneration |
| 02/12/2009 | US20090043076 Modified interferon beta with reduced immunogenicity |
| 02/12/2009 | US20090043073 Alpha-fetoprotein peptides and uses for imaging |
| 02/12/2009 | US20090042992 Polymorphs of suberoylanilide hydroxamic acid |
| 02/12/2009 | US20090042827 Antiviral oligonucleotides targeting hbv |
| 02/12/2009 | US20090042809 Blood Pressure Lowering Protein Hydrolysates |
| 02/12/2009 | US20090042808 Use of mitochondria-targeted electron scavengers as anti-inflammatory agents |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042806 Transglutaminase inhibitors and methods of use thereof |
| 02/12/2009 | US20090042805 Peptides Useful As Dual Caspase-2/-6 Inhibitors And Their Biological Applications |
| 02/12/2009 | US20090042804 Novel peptide amphiphiles having improved solubility and methods of using same |
| 02/12/2009 | US20090042803 Inhibitors of protein kinases and uses thereof |
| 02/12/2009 | US20090042802 Compounds and peptides that bind the kgf receptor |
| 02/12/2009 | US20090042801 Method for inhibiting infection and reproduction of influenza type A WSN virus |
| 02/12/2009 | US20090042800 Assay |
| 02/12/2009 | US20090042799 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 02/12/2009 | US20090042798 T cell receptors and related materials and methods of use |
| 02/12/2009 | US20090042797 Gamma-heregulin |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042795 Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation |
| 02/12/2009 | US20090042794 Group b streptococcus antigens and corresponding dna fragments |
| 02/12/2009 | US20090042793 Novel Antiviral Therapies |
| 02/12/2009 | US20090042792 18 human secreted proteins |
| 02/12/2009 | US20090042791 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/12/2009 | US20090042790 Transmucosal delivery of peptide derivatives |
| 02/12/2009 | US20090042789 Method for Improving Symptom of Mood Disorder |
| 02/12/2009 | US20090042788 Peptides and chemical compound for inhibition of SHP2 function |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042786 Kunitz-type recombinant inhibitor |